-»This version is meant for browsers without CSS support mainly for visually disabled users. For a more advanced layout please use a more recent browser like Firefox 2.0 or Internet Explorer 7.«-
Classification of activities using the viruses HBV, HCV, HDV and HGV
This new recommendation is intended to assist in the classification of activities using group 3** hepatitis viruses (HBV and HCV), as well as other hepatitis viruses (HDV and HGV).
Recommendation HBV, HCV, HDV, HGV
Safe handling of human and animal cells and cell cultures
This recommendation has been completely revised and helps to support users in the assessment of risks for the safe handling of human and animal cells and cell cultures in contained systems.
Recommendation cells and cell cultures
Classification of work with genetically modified viral vectors
The recommendation on the classification of work with genetically modified viral vectors has been updated and supplemented with two additional commonly used vectors: Adeno-associated and Herpes simplex vectors.
Treatment and disposal of waste produced in contained systems
The SECB recommendation on the treatment and disposal of waste containing genetically modified or pathogenic organisms has also been completely revised and now covers all types of wastes produced in contained systems.
Recommendation on treatment and disposal of waste
Programme for Monitoring the Impacts of Streptomycin Use in Fire Blight Control
In January 2008, the antibiotic streptomycin was approved for the first time in Switzerland for treatment of fire blight in orchards. Its use is contingent on various conditions. For example, monitoring is required. The Swiss Expert Committee for Biosafety SECB believes it is essential that in addition to studies on the development of resistance in Erwinia amylovora (the causal agent of fire blight), other issues be taken into account as well. In cooperation with various federal agencies, research institutions, and other experts, SECB has therefore launched an interdisciplinary monitoring project. The main purpose of this programme is to gain an objective assessment of the real risks of streptomycin treatments using state of the art scientific methodologies.
The SECB, a permanent federal advisory committee, advises the Federal Council and the federal agencies on the drafting of laws, ordinances, guidelines and recommendations.
It advises the federal and cantonal authorities on the enforcement of these regulations.
It issues statements on licence applications and publishes recommendations on safety measures for studies using genetically modified or pathogenic organisms.
Contained systems (laboratories, greenhouses ...) and pathogenic or genetically modified organisms | Experimental releases of genetically modified organisms (wheat, maize, potatoes) |
Marketing of genetically modified or pathogenic organisms | Gene therapy (ex vivo and in vivo trials) |
Transport, import, export. Practical instructions for the transport, import and export of biological substances. | |